Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 211

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Ligand-Modulated Regulation of Progesterone Receptor Messenger Ribonucleic Acid and Protein in Human Breast Cancer Cell Lines

Open access
Read, Linnea D., Snider, Catherine E., Miller, Jean S., Greene, Geoffrey L., Katzeneilenbogen, Benita S.·1988·Molecular Endocrinology

Abstract

We have examined the effects of estrogen and progestin agonist and antagonist ligands on regulation of progesterone receptor (PR) protein and mRNA levels in a variety of human breast cancer cell lines. By Northern blot analysis, using human PR cDNA probes, PR mRNA in T47D and MCF-7 cells appears as five species of approximately 11.4, 5.8, 5.3, 3.5, and 2.8 kilobases. PR mRNA species are not detected in the PR protein-negative breast cancer cell lines MDA-MB-231 and LY2. T47D cells contain high levels of PR mRNA and protein (detected by hormone binding assay or Western blot analysis), and the PR protein and mRNA content of T47D cells are reduced to about 10% of the control level within 48 h of treatment with 10 nm promegestone; 17,21-dimethyl-19-nor-pregna-4,9-diene-3, 20-dione (R5020) or 16α-ethyl-21-hydroxy-19-nor-pregn-4-ene-3,20-dione (ORG2058), both potent progestins. In contrast, treatment of T47D cells with the antiprogestin 17β-hydroxy-110-[4-dimethylaminophenyl]-17α-(1-propynyl)-estra-4, 9-dien-3-one) (RU38486)reduces PR protein and mRNA levels only transiently. PR protein and mRNA are virtually undetectable in control MCF-7 cells grown in the absence of estrogens. When estradiol is administered to MCF-7 cells, the PR mRNA and protein levels increase gradually and proportionately (10- or 40-fold, respectively, in 3 days). This estradiol stimulation of PR is repressed to basal levels if MCF-7 cells receive a 100-fold excess of the antiestrogen 6-hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-[2-1 -pyrrolidinyl) ethoxy]phenylketone; LY117018) concomitantly. After estrogen stimulation of PR in MCF-7 cells, treatment with R5020 or RU38486 results in aca. 50% decrease in PR protein and mRNA content by 2 days. These studies reveal a close correspondence between changes in PR mRNA content and the PR protein content of cells in response to estrogen, antiestrogen, progestin, or antiprogestin exposure, suggesting that the changes in cellular PR protein are accounted for predominantly by changes at the transcriptional (RNA) level.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/mend-2-3-263

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 211

Metadata

Authors
Read, L. D., Snider, C. E., Miller, J. S., Greene, G. L., & Katzeneilenbogen, B. S.
Venue
Molecular Endocrinology
Published
1988-03
Volume
2
Issue
3
Pages
263-271
ISSN
  • 0888-8809 (ISSN-L)
  • 1944-9917
OpenAlex
W2042571781
Cited by
211
References
2
FWCI
12.41
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ligand-Modulated Regulation of Progesterone Receptor Messenger Ribonucleic Acid and Protein in Human Breast Cancer Cell Lines. https://app.cochat.ai/papers/10.1210/mend-2-3-263
The paper
Read, L. D., Snider, C. E., Miller, J. S., Greene, G. L., & Katzeneilenbogen, B. S. (1988). Ligand-Modulated Regulation of Progesterone Receptor Messenger Ribonucleic Acid and Protein in Human Breast Cancer Cell Lines. Molecular Endocrinology. https://doi.org/10.1210/mend-2-3-263

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.